Featured Participatory Project: GlaxoSmithKline, the Diabetes Drug Avandia and Dr. John Buse

The United States Senate Committee on Finance has released a damning staff report titled The Intimidation of Dr. John Buse and the Diabetes Drug Avandia.

Yes

Roving Reporter

Former Bush administration political advisor Karl Rove has signed on as a columnist for Newsweek magazine, with his first column titled "How to Beat Hillary (Next) November." Charles Kaiser notes the irony in Rove's decision to join the mainstream media: "In public, Rove is one of dozens of conservatives who assiduously bash the press.

No

Pages

Subscribe to PR Watch RSS